NCT01955642View on ClinicalTrials.gov

Evaluation of the Biological Response to Clopidogrel in Patients With Ischemic Stroke

CompletedOBSERVATIONAL
Enrollment

91

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Brain IschemiaIschemic Attack
Interventions
DRUG

Clopidogrel

75 mg milligrams per days of PLAVIX

Trial Locations (1)

42000

CHU de Saint-Etienne, Saint-Etienne

All Listed Sponsors
collaborator

Groupe de Recherche sur la Thrombose

OTHER

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT01955642 - Evaluation of the Biological Response to Clopidogrel in Patients With Ischemic Stroke | Biotech Hunter | Biotech Hunter